Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

Autor: Adilaa, Oyunchimeg, Alexandru, Sofia, Bellenger, Katharine, Bennet, Jaclyn, Bennet, Deborah, Bindroo, Priyanka, Borisagar, Ghanshyam, Cook, Claire, Dalai, Doljinsuren, Davis, Andrew, de Jong, Bouke, Dodds, Wendy, Duckworth, Lynette, Gahima, Nonhlanhla, Gebreegziabher, Belay, Goldfeld, Anne, Hanifa, Mahmud, Hughes, Gareth, Kimuli, Ivan, Komrska, Jan, Lomtadze, Nino, Murphy, Brendan, Mwelase, Thando, Nalunjogi, Joanitah, Patel, Leena, Pirlog, Irina, Qawiy, Ishmael, Rauchenberger, Mary, Rigouts, Leen, Roach, Carol, Rosu, Laura, Santos-Filho, Ezio, Senguttuvan, Thirumaran, Sisay, Million, Sridhar, Rathinam, Srinivasulu, Vignes, Teferi, Mekonnen, Teklu, Helen, Tsegeen, Narangarav, van Amsterdam, Odette, White, Lisa, Whitney, Johanna, Zagd, Chuluunbaatar, Goodall, Ruth L ^*, Meredith, Sarah K, Nunn, Andrew J, Bayissa, Adamu, Bhatnagar, Anuj K, Bronson, Gay, Chiang, Chen-Yuan, Conradie, Francesca, Gurumurthy, Meera, Kirenga, Bruce, Kiria, Nana, Meressa, Daniel, Moodliar, Ronelle, Narendran, Gopalan, Ngubane, Nosipho, Rassool, Mohammed, Sanders, Karen, Solanki, Rajesh, Squire, S Bertel, Torrea, Gabriela, Tsogt, Bazarragchaa, Tudor, Elena, Van Deun, Armand, Rusen, I D

Publikováno v: In The Lancet 26 November-2 December 2022 400(10366):1858-1868

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial.

Autor: Goodall RL; MRC Clinical Trials Unit at UCL, University College London, London, UK. Electronic address: r.goodall@ucl.ac.uk., Nunn AJ; MRC Clinical Trials Unit at UCL, University College London, London, UK., Meredith SK; MRC Clinical Trials Unit at UCL, University College London, London, UK., Bayissa A; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Bhatnagar AK; Rajan Babu Institute for Pulmonary Medicine & Tuberculosis, Delhi, India., Chiang CY; Department of Internal Medicine, Wan Fang Hospital, Taipei, Taiwan; School of Medicine, Taipei Medical University, Taipei, Taiwan; International Union Against Tuberculosis and Lung Disease, Paris, France., Conradie F; Empilweni TB Hospital, Gqeberha (Port Elizabeth), South Africa., Gopalan N; ICMR-National Institute for Research in Tuberculosis, Chennai, India., Gurumurthy M; Vital Strategies, Singapore., Kirenga B; Makerere University Lung Institute, Mulago Hospital, Kampala, Uganda., Kiria N; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia., Meressa D; St Peter's Tuberculosis Specialized Hospital and Global Health Committee, Addis Ababa, Ethiopia., Moodliar R; THINK: Tuberculosis & HIV Investigative, Doris Goodwin Hospital, Pietermaritzburg, South Africa., Ngubane N; King Dinuzulu Hospital Complex, Durban, South Africa., Rassool M; Clinical HIV Research Unit, Helen Joseph Hospital, Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa., Sanders K; MRC Clinical Trials Unit at UCL, University College London, London, UK., Solanki R; B J Medical College, Ahmedabad, India., Squire SB; Liverpool School of Tropical Medicine, Liverpool, UK., Teferi M; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Torrea G; Institute of Tropical Medicine, Antwerp, Belgium., Tsogt B; Mongolian Anti-Tuberculosis Coalition, Ulaanbaatar, Mongolia., Tudor E; Institute of Phthisiopneumology 'Chiril Draganiuc', Chisinau, Moldova., Van Deun A; Institute of Tropical Medicine, Antwerp, Belgium., Rusen ID; Vital Strategies, New York, NY, USA.

Publikováno v: The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Oct 01. Date of Electronic Publication: 2024 Oct 01.